Iambic Therapeutics, Inc. Common Stock (IAM)

Iambic Therapeutics, Inc. Common Stock (IAM) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $775M; returns 1 day -2.8%.

IAM financial model: income statement, cash flow and balance sheet